Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
Transplantation Proceedings|April 30, 2013
New perspectives of immunosuppressionF Halleck, F Friedersdorff, T F Fuller, et al.
Transplantation Proceedings|December 21, 2010
Why rejections are not biopsy proven: frequency and reasonsF Fleiner, P Glander, L Fritsche, et al.
Der Urologe. Ausg. A|December 6, 2005
[Modern immunosuppression following renal transplantation. Standard or tailor made?]K Budde, M Giessing, L Liefeldt, et al.
European Journal of Medical Research|June 11, 2005
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patientsK Budde, L Fritsche, J Waiser, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Treating type 2 diabetes in renal insufficiency: the role of pioglitazoneL Fritsche, K Budde, P Glander, et al.
Transplantation Proceedings|September 20, 2017
Late Conversion to Belatacept After Kidney Transplantation: Outcome and Prognostic FactorsM Dürr, N Lachmann, B Zukunft, et al.
Transplantation Proceedings|December 10, 2016
Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant PatientsS Brakemeier, M Dürr, F Bachmann, et al.
Transplantation Proceedings|March 26, 2004
Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipientsK Budde, P Glander, F Diekmann, et al.
European Journal of Medical Research|June 11, 2005
Problems of cyclosporine absorption profiling using C2-monitoringM Schuetz, G Einecke, I Mai, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipientsP Glander, P Hambach, K P Braun, et al.
Pageof 28